Related Experiment Video

Updated: Apr 30, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.3K

Studies on the anti-inflammatory effect and its mechanisms of sophoridine

Xiumei Huang1, Bo Li2, Lianzhong Shen2

  • 1National Institutes for Food and Drug Control, Beijing 100050, China ; Qinghai Province Institute for Food and Drug Control, Xining 810003, China.

Journal of Analytical Methods in Chemistry
|May 10, 2014
PubMed

Insights

Sophoridine demonstrates significant anti-inflammatory properties by reducing key inflammatory mediators like IL-8 and TNF-α. This study highlights its potential therapeutic benefits in managing inflammatory conditions.

Area of Science:

  • Pharmacology
  • Immunology
  • Natural Products

Background:

  • Inflammation is a complex biological response implicated in numerous diseases.
  • Identifying novel anti-inflammatory compounds is crucial for therapeutic development.
  • Sophoridine is a compound with potential medicinal applications.

Purpose of the Study:

  • To investigate the anti-inflammatory effects of sophoridine.
  • To elucidate the underlying mechanisms of sophoridine's anti-inflammatory action.
  • To evaluate sophoridine's impact on key inflammatory mediators in vitro and in vivo.

Main Methods:

  • In vitro models using lipopolysaccharide (LPS)-stimulated mouse peritoneal macrophages and HL-60 cells.
  • In vivo carrageenan-induced mouse paw edema model.
  • Measurement of inflammatory mediators (TNF-α, IL-6, PGE2, IL-8) using MTT assay, ultraviolet spectrophotometry, and radioimmunoassay.

Main Results:

  • Sophoridine significantly inhibited the production of Interleukin-8 (IL-8) in vitro.
  • Sophoridine reduced Tumor Necrosis Factor-alpha (TNF-α), Prostaglandin E2 (PGE2), and IL-8 in vivo.
  • No significant effect of sophoridine on Interleukin-6 (IL-6) production was observed in either model.

Conclusions:

  • Sophoridine exhibits notable anti-inflammatory activity.
  • The anti-inflammatory mechanism of sophoridine involves the inhibition of specific cytokine and inflammatory mediator production.
  • Sophoridine shows promise as a therapeutic agent for inflammatory diseases.

Related Concept Videos

Antiasthma Drugs: Methylxanthines01:24

Antiasthma Drugs: Methylxanthines

Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
2.0K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
753
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
701
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
691
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents01:17

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
1.0K